Gender Differences, Hyperuricemia and Brain Natriuretic Factor.
作者信息
Breuer Gabriel S, Nesher Gideon
机构信息
Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel; Rheumatoloy Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Hebrew University School of Medicine, Jerusalem, Israel.
Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel; Rheumatoloy Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Hebrew University School of Medicine, Jerusalem, Israel.
出版信息
Am J Med Sci. 2020 Dec;360(6):611-612. doi: 10.1016/j.amjms.2020.07.003. Epub 2020 Jul 6.
Abstract
摘要
相似文献
1
Gender Differences, Hyperuricemia and Brain Natriuretic Factor.性别差异、高尿酸血症与脑钠肽
Am J Med Sci. 2020 Dec;360(6):611-612. doi: 10.1016/j.amjms.2020.07.003. Epub 2020 Jul 6.
2
3
Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome.B型利钠肽在鉴别非ST段抬高型急性冠状动脉综合征后死亡风险患者中的附加价值。
Eur Heart J Acute Cardiovasc Care. 2014 Jun;3(2):132-40. doi: 10.1177/2048872614520753. Epub 2014 Jan 21.
4
N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.N末端前脑钠肽可改善ST段抬高型心肌梗死患者临床结局的C-ACS风险评分预测。
BMC Cardiovasc Disord. 2016 Dec 12;16(1):255. doi: 10.1186/s12872-016-0430-0.
5
N-terminal pro-brain natriuretic peptide and high-sensitivity troponin in the evaluation of acute chest pain of uncertain etiology. A PITAGORAS substudy.N末端前脑钠肽和高敏肌钙蛋白在评估病因不明的急性胸痛中的应用。一项毕达哥拉斯研究的子研究。
Rev Esp Cardiol (Engl Ed). 2013 Jul;66(7):532-8. doi: 10.1016/j.rec.2012.11.004. Epub 2013 Jan 29.
6
[Is it practical to use measurement of BNP and NT-proBNP levels in patients with acute coronary syndromes?].
Kardiol Pol. 2009 Nov;67(11):1207-9.
7
N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.N 末端前 B 型利钠肽在预测急性冠状动脉综合征后的早期和晚期死亡率方面补充了全球急性冠状动脉事件注册（GRACE）风险评分。
Clin Sci (Lond). 2009 Jun 2;117(1):31-9. doi: 10.1042/CS20080419.
8
Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF).降尿酸药物非布司他对慢性心力衰竭合并高尿酸血症患者影响的随机试验（LEAF-CHF）
Int Heart J. 2018 Sep 26;59(5):976-982. doi: 10.1536/ihj.17-560. Epub 2018 Aug 11.
9
High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome.高血清尿酸水平可预测急性冠脉综合征患者冠状动脉疾病的严重程度。
Angiology. 2012 Aug;63(6):448-52. doi: 10.1177/0003319711426868. Epub 2011 Nov 17.
10
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.黄嘌呤氧化酶抑制剂对慢性心力衰竭合并高尿酸血症患者的影响：托匹司他与别嘌醇对比的前瞻性随机对照临床试验——研究方案
Clin Exp Nephrol. 2018 Dec;22(6):1379-1386. doi: 10.1007/s10157-018-1599-6. Epub 2018 Jun 18.
本文引用的文献
1
Association Between Uric Acid and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Unstable Angina Pectoris.不稳定型心绞痛患者血尿酸与氨基末端 B 型利钠肽前体的相关性。
Am J Med Sci. 2020 Jul;360(1):64-71. doi: 10.1016/j.amjms.2020.04.004. Epub 2020 Apr 10.
2
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.男性和女性心力衰竭患者中血管紧张素转换酶 2 的循环血浆浓度及其对肾素-血管紧张素-醛固酮抑制剂的影响。
Eur Heart J. 2020 May 14;41(19):1810-1817. doi: 10.1093/eurheartj/ehaa373.
3
Uric Acid Level as a Predictor of Long-Term Mortality in Advanced Age Population.尿酸水平可预测高龄人群的长期死亡率。
Am J Med Sci. 2020 Jan;359(1):27-31. doi: 10.1016/j.amjms.2019.10.017. Epub 2019 Nov 7.
4
Prognostic value of serum uric acid in patients with acute heart failure: A meta-analysis.血清尿酸在急性心力衰竭患者中的预后价值：一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(8):e14525. doi: 10.1097/MD.0000000000014525.
5
The prognostic impact of the uric acid level in patients who require cardiovascular intensive care - is serum uric acid a surrogate biomarker for critical patients in the non-surgical intensive care unit?需要心血管重症监护的患者血尿酸水平的预后影响 - 血清尿酸是否是重症监护非外科病房重症患者的替代生物标志物？
Eur Heart J Acute Cardiovasc Care. 2020 Sep;9(6):636-648. doi: 10.1177/2048872618822473. Epub 2019 Jan 17.
6
Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan.性别差异对血管健康和整个生命周期中心血管疾病风险的内皮功能很重要。
Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1569-H1588. doi: 10.1152/ajpheart.00396.2018. Epub 2018 Sep 14.
7
Uric acid and cardiovascular disease.尿酸与心血管疾病。
Clin Chim Acta. 2018 Sep;484:150-163. doi: 10.1016/j.cca.2018.05.046. Epub 2018 May 24.
8
Hyperuricemia as a prognostic factor after acute coronary syndrome.高尿酸血症作为急性冠脉综合征后的预后因素。
Atherosclerosis. 2018 Feb;269:229-235. doi: 10.1016/j.atherosclerosis.2018.01.017. Epub 2018 Jan 17.
9
Uric acid level as predictor of mortality in the acute care setting of advanced age population.
Eur J Intern Med. 2017 Oct;44:74-76. doi: 10.1016/j.ejim.2017.07.021. Epub 2017 Jul 22.
10
Association of serum uric acid and cardiovascular disease in healthy adults.血清尿酸与健康成年人心血管疾病的关联。
Am J Cardiol. 2013 Apr 15;111(8):1146-51. doi: 10.1016/j.amjcard.2012.12.034. Epub 2013 Jan 24.
Zotero 插件